Australia's most trusted
source of pharma news
Posted 23 July 2024 PM
Dr Gisela Mautner - CEO of ASX-listed Noxopharm and former President of the Medical Affairs Professionals Association of Australasia (MAPA) - has won the inaugural Brooker Prize Impact Award for her outstanding work, walking away with peer recognition and a $10,000 cheque.
Mautner has headed the Sydney-based biotech for two and a half years, already notching a string of achievements. The company is building a growing pipeline of drugs based on two technology platforms - Chroma for oncology and Sofra for inflammation, autoimmunity and mRNA vaccine enhancement.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.